Taylor Alison Swift is an American singer-songwriter. She is known for narrative songs about her personal life, which have received widespread media coverage. At age 14, Swift became the youngest artist signed by the Sony/ATV Music publishing house and, at 15, she signed her first record deal.
Her 2006 eponymous debut album was the longest-charting album of the 2000s in the US. Its third single, "Our Song", made her the youngest person to single-handedly write and perform a number-one song on the Billboard Hot Country Songs chart. Swift's second album, Fearless, was released in 2008.
Buoyed by the pop crossover success of the singles "Love Story" and "You Belong with Me", it became the US' best-selling album of 2009 and was certified diamond in the US. The album won four Grammy Awards, and Swift became the youngest Album of the Year winner.
Scientist look for ways to extend the lives of our pet dogs in new study
dailyrecord.co.ukScientists are seeking ways to prolong the lives of our canine friends as part of a huge new study. Experts at the University of Washington have established the Dog Aging Project to see how they can ensure our beloved pooches live for two to four years longer.
The first of its three phases looked into the anti-rejection medicine rapamycin, and whether or not it could help in extending the lives of dogs.
The drug is already used in humans to aid their body in accepting kidney transplants, the Mirror reports. As part of the initial trials, 24 golden retrievers, German shepherds and labradors tested the drug - and it was found to have improved their hearts.
Following this, the scientists tried the drug out on 50 dogs as part of phase two, while also looking at the effect rapamycin has on a dog's cognitive function and activity.Dr Matt Kaeberlein said: "We find that 10 weeks of low-dose rapamycin treatment in middle-aged dogs is well-tolerated, with no overt side effects relative to placebo, and with improvements in left ventricular cardiac function that are comparable to what has been previously reported from a similar regimen in middle-aged mice."However, despite rapamycin being shown to improve the lifespan of mice, it did not appear to have the same impact on dogs, prompting the scientists to expand their number of test subjects for phrase three."While there is evidence that rapamycin improves age-related deterioration of cardiac function in laboratory mice, no such effect has been demonstrated in dogs or other animals existing in a natural environment," added Dr Matt Kaeberlein."Our study provides the first evidence that rapamycin may partially reverse age-related heart dysfunction in dogs by improving measures of
Read more on dailyrecord.co.uk
